Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of British Columbia
$27,000.00
Uncovering the sex-specific contribution of astroglial M1 muscarinic receptor signaling to Alzheimer’s disease pathophysiology
FY 2025-26
Summary
Alzheimer’s disease is a brain disorder that slowly erodes memory, thinking, and independence, placing a heavy burden on families and the health-care system in Canada. This disease affects women more often than men, although the reasons for this difference remain unclear. Currently, there is no cure for Alzheimer’s disease, and existing treatments offer only limited benefits. Key changes in Alzheimer’s disease include the build-up of toxic molecules called beta-amyloid and tau in the brain. These molecules can interfere with an important switch on brain cells known as the M1 receptor, which normally helps support learning and memory. When this switch does not work properly, brain cells struggle to communicate effectively. Existing drugs that turn the M1 switch directly on can temporarily improve thinking but often cause serious side effects, including seizures and digestive problems, which has limited their clinical use. One possible reason for these problems is that we still do not fully understand how this switch works in different types of brain cells. Understanding this, is the key focus of this project. In this project, we will study brain cells from male and female mice to see how beta-amyloid and tau change the way the M1 switch works and how these changes harm the cells. We will also add female and male hormones to these cells to test whether hormones can help explain why Alzheimer’s disease, and responses to some of the current treatments, differ between males and females. The long-term goal is to develop safer, more effective, and possibly sex-specific treatments for people living with Alzheimer’s disease.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
573341
Name
Teymouri Nima
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Uncovering the sex-specific contribution of astroglial M1 muscarinic receptor signaling to Alzheimer’s disease pathophysiology
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Alzheimer’S Disease; Astrocytes; Beta-Amyloid; G-Protein Coupled Receptors; Glial Cells; Intracellular Signaling; M1 Muscarinic Receptor; Neurodegeneration; Primary Cell Culture; Sex Differences
Abstract
Alzheimer’s disease is a brain disorder that slowly erodes memory, thinking, and independence, placing a heavy burden on families and the health-care system in Canada. This disease affects women more often than men, although the reasons for this difference remain unclear. Currently, there is no cure for Alzheimer’s disease, and existing treatments offer only limited benefits. Key changes in Alzheimer’s disease include the build-up of toxic molecules called beta-amyloid and tau in the brain. These molecules can interfere with an important switch on brain cells known as the M1 receptor, which normally helps support learning and memory. When this switch does not work properly, brain cells struggle to communicate effectively. Existing drugs that turn the M1 switch directly on can temporarily improve thinking but often cause serious side effects, including seizures and digestive problems, which has limited their clinical use. One possible reason for these problems is that we still do not fully understand how this switch works in different types of brain cells. Understanding this, is the key focus of this project. In this project, we will study brain cells from male and female mice to see how beta-amyloid and tau change the way the M1 switch works and how these changes harm the cells. We will also add female and male hormones to these cells to test whether hormones can help explain why Alzheimer’s disease, and responses to some of the current treatments, differ between males and females. The long-term goal is to develop safer, more effective, and possibly sex-specific treatments for people living with Alzheimer’s disease.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Teymouri, Nima
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~